Fate Therapeutics

FATE

Börsenwert 214 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Fidelity Investments Boston, Massachusetts	7,32 Mio. $	–	–	–
2	PVMCV 2 Polaris Venture Management Co V Boston, Massachusetts	4,2 Mio. $	–	–	–
3	KCM 3 Kingdon Capital Management New York	3,84 Mio. $	–	–	–
4	4 Redmile Group San Francisco, California	2,55 Mio. $	+27.558 $	+15.200	+1 %
5	5 Vanguard Group Malvern, Pennsylvania	1,12 Mio. $	+40.064 $	+22.098	+3 %
6	6 Franklin Resources San Mateo, California	850.000 $	–	–	–
7	BGA 7 Belmont Global Advisors Dallas, Texas	680.000 $	-148.666 $	-82.000	-17 %
8	8 Bridgeway Capital Management Houston, Texas	671.000 $	-145.040 $	-80.000	-17 %
9	BOTOTLSJU 9 Board of Trustees of The Leland Stanford Junior University Redwood City, California	495.000 $	+9.272 $	+5.114	+2 %
10	10 Lombard Odier Asset Management (USA) New York	436.000 $	+12.785 $	+7.052	+3 %
11	11 Renaissance Technologies New York	307.000 $	-76.146 $	-42.000	-19 %
12	12 Jacobs Levy Equity Management Florham Park, New Jersey	304.000 $	-46.775 $	-25.800	-13 %
13	13 Geode Capital Management Boston, Massachusetts	183.000 $	–	–	–
14	TI 14 Telemetry Investments New York	144.000 $	-20.850 $	-11.500	-12 %
15	15 Emerald Acquisition Seattle, Washington	137.000 $	+146.135 $	+80.604	Neu
16	16 BlackRock Fund Advisors San Francisco, California	128.000 $	+28.466 $	+15.701	+26 %
17	17 Bank of New York Mellon New York	117.000 $	+8.958 $	+4.941	+8 %
18	18 Goldman Sachs New York	61.000 $	-250.118 $	-137.958	-79 %
19	19 Bank of America Charlotte, North Carolina	48.000 $	+167 $	+92	+0,3 %
20	20 Northern Trust Chicago, Illinois	43.000 $	–	–	–
21	21 Nationwide Fund Advisors Columbus, Ohio	38.000 $	–	–	–
22	22 Tocqueville Asset Management New York	37.000 $	–	–	–
23	TC 23 TFS Capital West Chester, Pennsylvania	36.000 $	+37.937 $	+20.925	Neu
24	24 Allianz Asset Management Munich, Germany	31.000 $	-324.667 $	-179.077	-91 %
25	25 Deutsche Bank Frankfurt Am Main Ge, Germany	30.000 $	-46.527 $	-25.663	-59 %

Fate Therapeutics FATE Börsenwert 214 Mio. $

Fate Therapeutics

FATE

Börsenwert 214 Mio. $